🔎 Trials Near Me

Beranda › Gangguan Psikotik › California

Uji klinis Gangguan Psikotik di California

21 studi untuk Gangguan Psikotik mencari peserta di lokasi di California.

Kota di California

Teks studi resmi (Bahasa Inggris)

Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1

  • University of California, Irvine, Irvine
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 59 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07853807

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

  • Clinical Site, Anaheim
  • Clinical Site, Long Beach
  • Clinical Site, Murrieta
  • dan 2 lainnya
Menerima pesertaFase 2
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06887192

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

  • Advanced Research Center, Inc, Anaheim
  • Sunwise Clinical Research, Walnut Creek
Menerima pesertaFase 2
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT06540833

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  • Advanced Research Center, Inc., Anaheim
  • Inland Psychiatric Medical Group (IPMG)-Chino, Chino
  • USC - The Memory and Aging Center (MAC) - Alzheimer Disease Research Center (ADRC), Los Angeles
Menerima pesertaFase 3
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06585787

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

  • Neurocrine Clinical Site, Chino
  • Neurocrine Clinical Site, Fresno
  • Neurocrine Clinical Site, Long Beach
  • dan 3 lainnya
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07105111

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

  • Clinical Site, Bellflower
  • Clinical Site, Cerritos
  • Clinical Site, Culver City
  • dan 12 lainnya
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT07459647

Enhancing Veteran-Clinical Collaboration in VA PRRCs

  • VA San Diego Healthcare System, San Diego, CA, San Diego
  • VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT06898879

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

  • BioXcel Clinical Research Site, Anaheim
Menerima pesertaFase 1
Usia 10 hingga 17 · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT05025605

Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode

  • UCLA Aftercare Research Program, Los Angeles
Menerima peserta
Usia 18 hingga 45 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT05890183

Determining the Role of Social Reward Learning in Social Anhedonia

  • University of California Los Angeles, Los Angeles
Menerima peserta
Usia 18 hingga 35 · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT05617898

A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness

  • VA San Diego Healthcare System, San Diego, CA, San Diego
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jul 2026 · NCT05537376

A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)

  • Inland Psychiatric Medical Group., Chino
Menerima pesertaFase 3
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 30 Jun 2026 · NCT06947941

Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial

  • University of California, Los Angeles, Los Angeles
Menerima pesertaFase 4
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 4 Mei 2026 · NCT05208190

Brain Stimulation to the Hippocampus in Schizophrenia

  • Stanford University, Stanford
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 27 Feb 2026 · NCT07010614

Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness (R33)

  • University of California - San Diego, San Diego
Menerima peserta
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 23 Feb 2026 · NCT06865937

Neural Basis of Social Cognition Deficits

  • Loma Linda U, Loma Linda
Menerima peserta
Usia 12 hingga 18 · Semua jenis kelamin · Diperbarui 4 Feb 2026 · NCT05185128

Enhancing Rehabilitation for Veterans With Serious Mental Illness

  • VA San Diego Healthcare System, San Diego, CA, San Diego
Menerima peserta
Usia 18 hingga 83 · Semua jenis kelamin · Diperbarui 30 Jan 2026 · NCT06586164

Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy

  • UC San Diego, San Diego
Menerima peserta
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 23 Jan 2026 · NCT07098169

Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis

  • UC San Diego, La Jolla
  • University of California, San Diego, San Diego
Menerima pesertaFase 3
Usia 16 hingga 30 · Semua jenis kelamin · Diperbarui 8 Jan 2026 · NCT04411225

Sacramento Clinical High Risk for Psychosis Stepped-Care Program

  • River Oak Center for Children, Elk Grove
  • Turning Point Community Programs, Elk Grove
  • University of California Department of Psychiatry and Behavioral Sciences; Early Psychosis Programs, Sacramento
  • dan 3 lainnya
Menerima peserta
Usia 12 hingga 25 · Semua jenis kelamin · Diperbarui 15 Des 2025 · NCT06640803

Multiomic Diagnostics in Youth With Psychosis

  • Rady Children's Hospital San Diego, San Diego
Menerima peserta
Usia 7 hingga 17 · Semua jenis kelamin · Diperbarui 14 Nov 2024 · NCT05457140

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.